170 related articles for article (PubMed ID: 27704262)
1. Risk factors for same-admission mortality after pathologic fracture secondary to metastatic cancer.
Behnke NK; Baker DK; Xu S; Niemeier TE; Watson SL; Ponce BA
Support Care Cancer; 2017 Feb; 25(2):513-521. PubMed ID: 27704262
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment for pathologic fracture.
Wedin R
Acta Orthop Scand Suppl; 2001 Jun; 72(302):2p., 1-29. PubMed ID: 11582636
[TBL] [Abstract][Full Text] [Related]
3. What Factors Are Associated With Early Mortality in Patients Undergoing Femur Surgery for Metastatic Lung Cancer?
Kim JH; Seo SW; Chung CH
Clin Orthop Relat Res; 2018 Sep; 476(9):1815-1822. PubMed ID: 30794217
[TBL] [Abstract][Full Text] [Related]
4. Nationwide Patterns of Pathologic Fractures Among Patients Hospitalized With Bone Metastases.
Jairam V; Lee V; Yu JB; Park HS
Am J Clin Oncol; 2020 Oct; 43(10):720-726. PubMed ID: 32694296
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pathologic fractures of the proximal femur.
Angelini A; Trovarelli G; Berizzi A; Pala E; Breda A; Maraldi M; Ruggieri P
Injury; 2018 Nov; 49 Suppl 3():S77-S83. PubMed ID: 30415673
[TBL] [Abstract][Full Text] [Related]
6. High Risk of Venous Thromboembolism After Surgery for Long Bone Metastases: A Retrospective Study of 682 Patients.
Groot OQ; Ogink PT; Janssen SJ; Paulino Pereira NR; Lozano-Calderon S; Raskin K; Hornicek F; Schwab JH
Clin Orthop Relat Res; 2018 Oct; 476(10):2052-2061. PubMed ID: 30179923
[TBL] [Abstract][Full Text] [Related]
7. Complications and survival after surgical treatment of 214 metastatic lesions of the humerus.
Wedin R; Hansen BH; Laitinen M; Trovik C; Zaikova O; Bergh P; Kalén A; Schwarz-Lausten G; Vult von Steyern F; Walloe A; Keller J; Weiss RJ
J Shoulder Elbow Surg; 2012 Aug; 21(8):1049-55. PubMed ID: 21982491
[TBL] [Abstract][Full Text] [Related]
8. External Validation and Optimization of the SPRING Model for Prediction of Survival After Surgical Treatment of Bone Metastases of the Extremities.
Sørensen MS; Gerds TA; Hindsø K; Petersen MM
Clin Orthop Relat Res; 2018 Aug; 476(8):1591-1599. PubMed ID: 30020148
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors following pathological fractures.
Hill T; D'Alessandro P; Murray K; Yates P
ANZ J Surg; 2015 Mar; 85(3):159-63. PubMed ID: 25182567
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous vertebroplasty and kyphoplasty for pathologic vertebral fractures in the Medicare population: safer and less expensive than open surgery.
Itagaki MW; Talenfeld AD; Kwan SW; Brunner JW; Mortell KE; Brunner MC
J Vasc Interv Radiol; 2012 Nov; 23(11):1423-9. PubMed ID: 23101914
[TBL] [Abstract][Full Text] [Related]
11. What Is the Adverse Event Profile After Prophylactic Treatment of Femoral Shaft or Distal Femur Metastases?
McLynn RP; Ondeck NT; Grauer JN; Lindskog DM
Clin Orthop Relat Res; 2018 Dec; 476(12):2381-2388. PubMed ID: 30260860
[TBL] [Abstract][Full Text] [Related]
12. Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients.
Bauer HC; Wedin R
Acta Orthop Scand; 1995 Apr; 66(2):143-6. PubMed ID: 7740944
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic Versus Postfracture Stabilization for Metastatic Lesions of the Long Bones: A Comparison of 30-day Postoperative Outcomes.
El Abiad JM; Raad M; Puvanesarajah V; Rao SS; Morris CD; Levin AS
J Am Acad Orthop Surg; 2019 Aug; 27(15):e709-e716. PubMed ID: 31344005
[TBL] [Abstract][Full Text] [Related]
14. Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?
Howard LE; De Hoedt AM; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Divers CH; Valderrama A; Freedland SJ
Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):380-384. PubMed ID: 27377207
[TBL] [Abstract][Full Text] [Related]
15. Predictors of survival after intramedullary nail fixation of completed or impending pathologic femur fractures from metastatic disease.
Kotian RN; Puvanesarajah V; Rao S; El Abiad JM; Morris CD; Levin AS
Surg Oncol; 2018 Sep; 27(3):462-467. PubMed ID: 30217303
[TBL] [Abstract][Full Text] [Related]
16. Is Prophylactic Intervention More Cost-effective Than the Treatment of Pathologic Fractures in Metastatic Bone Disease?
Blank AT; Lerman DM; Patel NM; Rapp TB
Clin Orthop Relat Res; 2016 Jul; 474(7):1563-70. PubMed ID: 27020430
[TBL] [Abstract][Full Text] [Related]
17. Orthopedic surgical management of skeletal complications of malignancy.
Harrington KD
Cancer; 1997 Oct; 80(8 Suppl):1614-27. PubMed ID: 9362429
[TBL] [Abstract][Full Text] [Related]
18. Is It Appropriate to Treat Sarcoma Metastases With Intramedullary Nailing?
Moon BS; Dunbar DJ; Lin PP; Satcher RL; Bird JE; Lewis VO
Clin Orthop Relat Res; 2017 Jan; 475(1):212-217. PubMed ID: 27804017
[TBL] [Abstract][Full Text] [Related]
19. Pathologic fracture in metastatic kidney cancer: Identifying widening disparities and opportunity for quality improvement.
Bhanvadia RR; Baky FJ; Ashbrook CQ; Lotan Y; Woldu SL
Urol Oncol; 2022 Aug; 40(8):384.e1-384.e8. PubMed ID: 35662499
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis and therapy of metastasis-induced pathologic fractures].
Schmidbauer G; Ecke H
Unfallchirurgie; 1992 Aug; 18(4):203-12. PubMed ID: 1384216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
